The largest database of trusted experimental protocols

The GCN2-KO-DR is a laboratory equipment product designed for cell culture research. It is a genetically modified cell line with the GCN2 gene knocked out. The core function of this product is to provide a cell line with a specific genetic modification for experimental purposes. No further details on the intended use or applications of this product can be provided in an unbiased and factual manner.

Automatically generated - may contain errors

2 protocols using gcn2 ko dr

1

Culturing Hepatoblastoma and Vero Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver human hepatoblastoma cells (HepG2), and Vero cells were cultured in complete DMEM (Gibco) media consisting of 10% FBS (GIBCO), 100 units/ml Penicillin, 1 μg/ml Streptomycin, L-Glutamine, and 1 mM sodium pyruvate. DR-Wildtype (ATCC CRL2977) and GCN2-KO-DR (ATCC CRL2978) MEFs were purchased from American Type Culture Collection (ATCC) and cultured in complete DMEM growth medium as described earlier (15 (link)). Halofuginone hydrobromide (trans-[±]-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4[3H]) quinazolinonemonohydrobromide and Actinomycin-D were purchased from Sigma-Aldrich; Lipofectamine 2000 (Invitrogen, Life Technologies). pNifty-Luc was purchased from Invivogen and pKM2L-phCOX-2 plasmid was purchased from RIKEN Bioresource Center (DNA Bank), Japan. pCDNA3.1-Flag-GCN2 plasmid was a kind gift from Prof. David Ron's lab, Cambridge University.
+ Open protocol
+ Expand
2

Macrophage Stimulation and Inhibition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DR-Wildtype (ATCC CRL2977) and GCN2-KO-DR (ATCC CRL2978) MEFs, purchased from American Type Culture Collection (ATCC), were maintained in DMEM containing 10% (vol/vol) FBS (Invitrogen), 100 units/ml penicillin, 100 μg/ml streptomycin, 2 mM L-Glutamine, 1 mM sodium pyruvate, and 0.05 mM 2-mercaptomethanol. Sodium thioglycolate (Sigma-Aldrich) was used to generate thioglycolate-elicited peritoneal macrophages. LPS (Sigma-Aldrich) and ATP (Sigma-Aldrich) were used at a concentration of 500ng/ml and 5mM, respectively, to stimulate BMDMs, peritoneal macrophages, or J774A.1 cells cultured in DMEM containing 10% (vol/vol) FBS (Invitrogen), 100 units/ml penicillin, 100 μg/ml streptomycin, 2 mM L-Glutamine, and 1 mM sodium pyruvate. HF hydrobromide (trans-[±]-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4[3H])quinazolinonemonohydrobromide (Sigma-Aldrich); 3-MA (Sigma-Aldrich), and Wortmannin (Sigma-Aldrich) were used at a concentration of 5 mM or 5 μM. Cycloheximide and Act-D (Sigma-Aldrich) were used at 1 μg/ml and 10 μg/ml. Rapamycin (Sigma-Aldrich) was used at a concentration of 200 nM. Lipofectamine 3000 was from Life Technologies (L3000015) and Sepharose G beads from Sigma-Aldrich. pCMV6 IL-1β was purchased from Origene.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!